Veno-arterial ECMO for Cardiogenic Shock

Activity Summary

This is a foundational review of current guidelines for the indications, relative contraindications and common complications of veno-arterial ECMO for cardiogenic shock as a bridge to recovery, durable device, transplant or to decision. The role of the APRN in the cannulation process, circuit maintenance and patient management, including sedation, anticoagulation, weaning and hemodynamic optimization with inotropes, vasopressors and parenteral antihypertensives is discussed. Pharmacology content = 30%

Objectives

Review current guidelines for the indications and relative contraindications of ECMO for cardiogenic shock.
Describe the ARPN’s role in circuit-related management, including cannulation, optimizing flow and weaning therapy.
Explain management of ECMO—hemodynamic optimization with inotropes, vasopressors and parenteral antihypertensives and anticoagulation.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.